标题
Targeting oncoproteins with a positive selection assay for protein degraders
作者
关键词
-
出版物
Science Advances
Volume 7, Issue 6, Pages eabd6263
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2021-02-09
DOI
10.1126/sciadv.abd6263
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
- (2020) George M. Burslem et al. CELL
- Development of CDK2 and CDK5 Dual Degrader TMX‐2172
- (2020) Nathanael Schiander Gray et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A Triple Knockout Isobaric-Labeling Quality Control Platform with an Integrated Online Database Search
- (2020) Jeremy P. Gygi et al. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
- Peptidic degron for IMiD-induced degradation of heterologous proteins
- (2019) Vidyasagar Koduri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion
- (2019) Isaac S. Harris et al. Cell Metabolism
- The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis
- (2019) Matthew G. Oser et al. GENES & DEVELOPMENT
- Efficient Synthesis of Immunomodulatory Drug Analogues Enables Exploration of Structure-Degradation Relationships
- (2018) George M. Burslem et al. ChemMedChem
- Streamlined Tandem Mass Tag (SL-TMT) Protocol: An Efficient Strategy for Quantitative (Phospho)proteome Profiling Using Tandem Mass Tag-Synchronous Precursor Selection-MS3
- (2018) José Navarrete-Perea et al. JOURNAL OF PROTEOME RESEARCH
- The dTAG system for immediate and target-specific protein degradation
- (2018) Behnam Nabet et al. Nature Chemical Biology
- Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN
- (2018) Quinlan L. Sievers et al. SCIENCE
- Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival
- (2018) Matthew G. Oser et al. Cancer Discovery
- Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes
- (2017) Monther Abu-Remaileh et al. SCIENCE
- The ORFeome Collaboration: a genome-scale human ORF-clone resource
- (2016) NATURE METHODS
- ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs
- (2016) Mark D. Borromeo et al. Cell Reports
- Achaete-Scute Homolog 1 Expression Controls Cellular Differentiation of Neuroblastoma
- (2016) Mumtaz Kasim et al. Frontiers in Molecular Neuroscience
- Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
- (2016) Zhenghu Chen et al. Scientific Reports
- Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma
- (2015) M. E. M. Dolman et al. CLINICAL CANCER RESEARCH
- Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma
- (2015) L. A. Wylie et al. Disease Models & Mechanisms
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Identification and characterization of essential genes in the human genome
- (2015) T. Wang et al. SCIENCE
- CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo
- (2015) G P Gregory et al. LEUKEMIA
- The phosphorylation status of Ascl1 is a key determinant of neuronal differentiation and maturation in vivo and in vitro
- (2014) F. R. Ali et al. DEVELOPMENT
- Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation
- (2014) John G Doench et al. NATURE BIOTECHNOLOGY
- ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
- (2014) A. Augustyn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
- (2013) Anita K. Gandhi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- Increasing the Multiplexing Capacity of TMTs Using Reporter Ion Isotopologues with Isobaric Masses
- (2012) Graeme C. McAlister et al. ANALYTICAL CHEMISTRY
- Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression
- (2012) Ling-Hua Zhang et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
- (2012) A Lopez-Girona et al. LEUKEMIA
- Cell Fate Control Gene Therapy Based on Engineered Variants of Human Deoxycytidine Kinase
- (2012) Anton Neschadim et al. MOLECULAR THERAPY
- Indole RSK inhibitors. Part 1: Discovery and initial SAR
- (2011) Stephen J. Boyer et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Indole RSK inhibitors. Part 2: Optimization of cell potency and kinase selectivity
- (2011) Thomas M. Kirrane et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
- (2011) Y. X. Zhu et al. BLOOD
- Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13
- (2011) Junli Liu et al. CELL
- Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
- (2010) David Parry et al. MOLECULAR CANCER THERAPEUTICS
- Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells
- (2009) J. J. Molenaar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started